EpiPen Recalled in Australia

Epipen 2 Pack

Alphapharm, the Australian subsidiary of Mylan, has recalled four batches of EpiPen brand 300µg epinephrine auto-injectors for a potentially defective part after two of the devices failed to activate, according to a report by ABC News, Australia.

The recalled product was manufactured by Meridian Medical Technologies in St. Louis Missouri and the devices have been distributed worldwide.

“The failure of the auto-injector to activate may result in patients not receiving the required dose of adrenaline, resulting in the worsening of symptoms of anaphylaxis or anaphylactic reactions, which could be life-threatening,” the company said.

Click to visit sponsor

The affected batches are:

Batch number Expiry
5FA665 April 2017
5FA6651 April 2017
5FA6652 April 2017
5FA6653 April 2017

We presume these batches have been in circulation for a while since the expiration dates are imminent.

Alphapharm said: “At this time, EpiPen Jr 150 microgram adrenaline injection syringe auto-injectors and all other batches of EpiPen 300 microgram adrenaline injection syringe auto-injectors are unaffected and are not subject to this recall.”

As of this writing, a recall has not been initiated in the US.

Print or share this article
Click to visit sponsor

Leave a Reply